P6 Extreme
Natural health product licensed in Canada
- Licence holder
- Nutrabolt Distribution Canada ULC
- NPN or DIN-HM
- 80027815
- Status
- Inactive licence
- Licence date
- 26 October 2011
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-Diindolylmethane Source : 3,3'-diindolylméthane | 13.5 mg | Not calculated |
| Dioscorea villosa Source : Extrait de racine Extraction ratio : 65:1 Dry plant equivalent : 1.495 mg | 23 mg | Not calculated |
| Trigonella foenum-graecum Source : Seed extract Extraction ratio : 7.5:1 Dry plant equivalent : 1.875 g | 250 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, FD & C bleu #1, Stéarate de magnésium, Sclareolide, Gélatine, Dioxyde de titane, FD & C Red #40 Aluminium Lake
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Black cohosh is used in Herbal Medicine to help relieve muscle or joint pain associated with rheumatic conditions. Fenugreek is used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Fenugreek is used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidemia. Fenugreek is used in Herbal Medicine as a nutritive tonic. In men, beta-sitosterol helps relieve symptoms associated with benign prostatic hyperplasia including poor urinary flow, incomplete voiding, and urinary pain or discomfort. In women, black cohosh is used in Herbal Medicine to help relieve premenstrual symptoms and the symptoms associated with menopause.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80027815
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.